Title
of Each Class
|
Name
of Each Exchange
on
Which Registered
|
American
Depositary Shares, each representing ten
Ordinary
Shares, without par value
|
New
York Stock Exchange
|
Ordinary
Shares, without par value
|
New
York Stock Exchange
(for
listing purposes only)
|
PART
I
|
1 | |
Item
1.
|
Identity
of Directors, Senior Management and Advisers
|
1
|
Item
2.
|
Offer
Statistics and Expected Timetable
|
1
|
Item
3.
|
Key
Information
|
1
|
Item
4.
|
Information
on the Company
|
9
|
Item
5.
|
Operating
and Financial Review and Prospects
|
25
|
Item
6.
|
Directors,
Senior Management and Employees
|
40
|
Item
7.
|
Major
Shareholders and Related Party Transactions
|
44
|
Item
8.
|
Financial
Information
|
46
|
Item
9.
|
Offer
and Listing Details
|
47
|
Item
10.
|
Additional
Information
|
49
|
Item
11.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
63
|
Item
12.
|
Description
of Securities Other than Equity Securities
|
63
|
PART
II
|
63
|
|
Item
13.
|
Defaults,
Dividend Arrearages and Delinquencies
|
63
|
Item
14.
|
Material
Modifications to the Rights of Security Holders and Use of
Proceeds
|
63
|
Item
15.
|
Controls
and Procedures
|
63
|
Item
16.
|
Reserved
|
63
|
PART
III
|
64
|
|
Item
17.
|
Financial
Statements
|
64
|
Item
18.
|
Financial
Statements
|
64
|
Item
19.
|
Exhibits
|
64
|
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS | F-1 |
·
|
International,
national and local general economic and market conditions;
|
· |
The
overall size and growth of the Mexican pharmaceutical market;
|
· |
The
level of competition among distributors, suppliers and sellers
of
pharmaceuticals;
|
· |
Fluctuations
and difficulty in forecasting operating
results;
|
· |
Dependence
on suppliers and clients;
|
· |
General
risks associated with doing business in Mexico, including political
and
economic instability and changes in government regulations;
and
|
· |
Other
factors referenced in this annual
report.
|
Year
ended December 31,
|
2000
|
2001
|
2002
|
2003
|
2004
|
2004
(1)
|
|
(in
thousands of constant Pesos as of December 31, 2004 and U.S. Dollars,
except share and per share data)
|
|||||||
Income
Statement
|
|||||||
Mexican
GAAP:
|
|||||||
Net
sales
|
Ps.
18,802,166
|
Ps.
18,771,000
|
Ps.
19,914,147
|
Ps.
20,545,077
|
Ps.
20,569,977
|
U.S.$1,833,609
|
|
Gross
profit
|
1,954,672
|
2,010,022
|
2,100,940
|
2,042,475
|
2,117,590
|
188,764
|
|
Operating
expenses
|
1,271,864
|
1,276,278
|
1,333,107
|
1,266,235
|
1,319,797
|
117,647
|
|
Operating
income, net
|
682,809
|
733,744
|
767,833
|
776,240
|
797,793
|
71,117
|
|
Comprehensive
cost of financing, net
|
93,597
|
163,844
|
16,981
|
48,699
|
15,794
|
1,407
|
|
Other
(income) (2)
|
(19,934)
|
(34,975)
|
(6,484)
|
(36,096)
|
(49,899)
|
(4,448)
|
|
Income
(loss) before taxes and employee profit sharing
|
609,145
|
604,875
|
757,336
|
763,637
|
831,898
|
74,158
|
|
Net
income (loss)
|
480,551
|
468,846
|
594,916
|
605,844
|
648,804
|
57,836
|
|
Net
income (loss) per Ordinary Share (3)
|
1.811
|
1.766
|
2.241
|
2.283
|
2.444
|
0.218
|
|
Weighted
average Ordinary Shares outstanding (in thousands) (3)
|
265,419
|
265,419
|
265,419
|
265,419
|
265,419
|
||
U.S.
GAAP (4):
|
|||||||
Net
sales
|
Ps.
18,802,166
|
Ps.
18,771,000
|
Ps.
19,914,147
|
Ps.
20,545,077
|
Ps.
20,569,977
|
U.S.$1,833,609
|
|
Gross
profit
|
1,954,672
|
2,010,023
|
2,100,940
|
2,042,475
|
2,117,590
|
188,764
|
|
Operating
income
|
860,674
|
762,345
|
739,020
|
837,900
|
797,793
|
71,117
|
|
Income
(loss) before taxes and employee profit sharing
|
787,005
|
633,476
|
728,521
|
825,297
|
831,898
|
1,407
|
|
Net
income (4)
|
658,416
|
497,448
|
566,104
|
667,503
|
648,804
|
57,836
|
Year
ended December 31,
|
2000
|
2001
|
2002
|
2003
|
2004
|
2004
(1)
|
|
(in
thousands of constant Pesos as of December 31, 2004 and U.S. Dollars,
except share and per share data)
|
|||||||
Net
income (loss) per Ordinary share (3)
|
2.4807
|
1.8742
|
2.1328
|
2.5149
|
2.4444
|
0.2180
|
|
Weighted
average Ordinary Shares outstanding (in thousands) (3)
|
265,419
|
265,419
|
265,419
|
265,419
|
265,419
|
—
|
|
Balance
Sheet Data
|
|||||||
Mexican
GAAP:
|
|||||||
Property
and equipment, net
|
Ps.
1,182,105
|
Ps.
1,098,546
|
Ps.
1,065,935
|
Ps.
1,034,959
|
Ps.
1,069,880
|
U.S.$
95,369
|
|
Total
assets
|
7,251,605
|
7,760,061
|
8,208,549
|
8,700,168
|
9,126,832
|
813,567
|
|
Short-term
debt
|
87,504
|
351,451
|
388,282
|
410,244
|
-
|
-
|
|
Long-term
debt (5)
|
734,060
|
438,157
|
47,027
|
0
|
-
|
||
Capital
stock
|
1,007,292
|
1,007,292
|
1,007,292
|
1,007,292
|
1,007,292
|
89,790
|
|
Total
stockholders’ equity (4)
|
2,792,144
|
3,033,473
|
3,260,403
|
3,514,373
|
4,033,065
|
359,508
|
|
U.S.
GAAP (4):
|
|||||||
Property
and equipment, net
|
Ps.
1,182,105
|
Ps.
1,098,546
|
Ps.
1,065,935
|
Ps.
1,034,959
|
Ps.
1,069,880
|
U.S.$
95,369
|
|
Total
assets
|
7,251,605
|
7,760,061
|
8,208,549
|
8,700,168
|
9,126,832
|
813,567
|
|
Short-term
debt
|
87,504
|
351,451
|
388,282
|
410,244
|
-
|
-
|
|
Long-term
debt(5)
|
734,060
|
438,157
|
47,027
|
0
|
-
|
||
Capital
stock
|
1,007,292
|
1,007,292
|
1,007,292
|
1,007,292
|
1,007,292
|
89,790
|
|
Total
stockholders’ equity (4)
|
2,791,311
|
3,061,242
|
3,222,881
|
3,538,510
|
4,057,202
|
361,659
|
|
· |
the
resolution by our shareholders in light of our results, financial
condition, cash requirements, future prospects and other factors
deemed
relevant by our shareholders for this
purpose;
|
· |
the
extent to which we receive cash dividends, advances and other payments
from our subsidiaries. We are a holding company with no significant
operating assets other than the ones we own through our subsidiaries.
Given the fact that we receive substantially all of our operating
income
from our subsidiaries, our ability to meet our financial obligations,
including the payment of dividends, depends significantly on the
dividend
payments we receive from our subsidiaries;
and
|
· |
the
extent to which we have cash available for distribution after funding
our
working capital needs, capital expenditures and
investments.
|
Exchange
Rate(1)
|
|||||||||||||
Year
ended December 31,
|
High
|
Low
|
Average(2)
|
Period
End
|
|||||||||
2000
|
10.09
|
9.18
|
9.46
|
9.62
|
|||||||||
2001
|
9.97
|
8.95
|
9.34
|
9.17
|
|||||||||
2002
|
10.43
|
9.00
|
9.66
|
10.43
|
|||||||||
2003
|
11.41
|
10.11
|
10.79
|
11.24
|
|||||||||
2004
|
11.64
|
10.81
|
11.30
|
11.15
|
|||||||||
Month
ended
|
|||||||||||||
December
31, 2004
|
11.33
|
11.11
|
11.20
|
11.15
|
|||||||||
January
30, 2005
|
11.41
|
11.17
|
11.26
|
11.21
|
|||||||||
February
28, 2005
|
11.21
|
11.04
|
11.14
|
11.09
|
|||||||||
March
31, 2005
|
11.33
|
10.98
|
11.16
|
11.18
|
|||||||||
April
30, 2005
|
11.23
|
11.04
|
11.11
|
11.08
|
|||||||||
May
31, 2005
|
11.03
|
10.89
|
10.98
|
10.91
|
|||||||||
June
15, 2005
|
10.88
|
10.81
|
10.85
|
10.83
|
· |
inflation
can adversely affect consumer purchasing power, thereby adversely
affecting consumer demand for the products we distribute;
and
|
· |
to
the extent inflation exceeds price increases, our prices and revenues
will
be adversely affected in “real”
terms.
|
Name
of Subsidiary(1)
|
Jurisdiction
of Incorporation
|
Percentage
Ownership(2)
|
Casa
Saba, S.A. de C.V.(3)
|
Mexico
|
99.9%
|
Drogueros,
S.A. de C.V.(4)
|
Mexico
|
99.9%
|
Grupo
Mexatar, S.A. de C.V.(5)
|
Mexico
|
99.9%
|
Centennial,
S.A. de C.V.(6)
|
Mexico
|
99.9%
|
Inmuebles
Visosil, S.A. de C.V.(7)
|
Mexico
|
99.9%
|
Publicaciones
CITEM, S.A. de C.V.(8)
|
Mexico
|
99.9%
|
Transportes
Marproa, S.A. de C.V.(9)
|
Mexico
|
99.9%
|
Servicios
Corporativos Saba, S.A. de C.V.(10)
|
Mexico
|
99.9%
|
Distribuidora
Casa Saba, S.A. de C.V. (11)
|
Mexico
|
99.9%
|
Other
companies (12)
|
Mexico
|
99.9%
|
(1)
|
With
the exception of Casa Saba, S.A. de C.V., none of our operating
subsidiaries is a “significant subsidiary” within the meaning of Rule
1-02(w) of Regulation S-X of the Securities Act of
1933.
|
(2)
|
Percentage
of equity owned by us directly or indirectly through subsidiaries
or
affiliates.
|
(3)
|
Direct
subsidiary through which we distribute pharmaceutical products
to private
and government clients.
|
(4)
|
Indirect
subsidiary through which we distribute pharmaceutical products
to private
and government clients.
|
(5)
|
Indirect
subsidiary through which we distribute office and electronic products,
including keyboards, audio and television equipment and related
accessories.
|
(6)
|
Indirect
subsidiary through which we distribute general merchandise and
other
products.
|
(7)
|
Indirect
subsidiary through which we lease real property to our other subsidiaries.
Inmuebles Visosil, S.A. de C.V. owns substantially all of the capital
stock of Drogueros, S.A. de C.V., another indirect subsidiary of
Grupo
Casa Saba.
|
(8)
|
Direct
subsidiary through which we distribute
publications.
|
(9)
|
Direct
subsidiary through which we deliver products to our distribution
centers
throughout Mexico. We place centralized purchase orders for all
of our
distribution centers directly with suppliers, who deliver these
centralized purchase orders to Transportes Marproa, S.A. de C.V.,
or
Marproa. Marproa then distributes customized orders to each of
our 22
distribution centers throughout Mexico. Marproa also provides freight
services to third parties at market
rates.
|
(10)
|
Indirect
subsidiary that provides administrative, legal, accounting, tax
planning,
financial counseling and other professional services to Casa Saba,
S.A. de
C.V.
|
(11)
|
Direct
subsidiary that provides logistical and transportation services
to Casa
Saba, S.A. de C.V.
|
(12)
|
Real
estate and Service companies
|
Year
ended December 31,
|
||||||||||
2002
|
2003
|
2004
|
||||||||
(Millions
of constant Pesos as of December 31, 2004)
|
||||||||||
Distribution
fleet
|
Ps |
32.8
|
Ps |
35.6
|
Ps. |
35.7
|
||||
Technology
and
computer
equipment
|
2.8
|
20.7
|
9.6
|
|||||||
Acquisitions
|
0.0
|
0.0
|
0.0
|
|||||||
Other
general capital
expenditures
|
0.0
|
0.7
|
1.0
|
|||||||
Total
capital expenditures
|
Ps |
35.6
|
Ps |
57.0
|
Ps. |
46.3
|
q |
5,300
pharmaceutical products;
|
q |
3,800
health and beauty products;
|
q |
890
general merchandise and other products, such as food, toiletries
and
electronics; and
|
q |
5,900
publications.
|
q |
more
than 18,000 pharmacies owned by private
individuals;
|
q |
approximately
3,000 privately-owned pharmacy chains and over 628 government
pharmacies;
|
q |
approximately
1,900 regional and national supermarkets;
|
q |
approximately
740 magazine stores, 200 racks and 170 nationwide
agents;
|
q |
over
70 department stores; and
|
q |
approximately
200 major wholesalers and 1,200 convenience
stores.
|
Year
Ended December 31,
|
||||||||||
2002
|
2003
|
2004
|
||||||||
Private
Pharmaceuticals(1)
|
81.4%
|
|
83.5%
|
|
83.6%
|
|
||||
Government
Pharmaceuticals
|
4.0%
|
|
2.7%
|
|
3.0%
|
|
||||
HBCG/Other
Products
|
10.7%
|
|
10.5%
|
|
9.9%
|
|
||||
Publications
|
3.9%
|
|
3.3%
|
|
3.5%
|
|
||||
Total
|
100.0%
|
|
100.0%
|
|
100.0%
|
|
· |
Focusing
our efforts on improving our profitability levels and operating
profit
generation, including by conducting ongoing analysis and evaluation
of the
profitability of each client and each distribution route and commercial
terms with the suppliers;
|
· |
Paying
off our cost-bearing liabilities in
full;
|
· |
Maintaining
state-of-the-art technology in all of our subsidiaries, as well
as a
renovating our transportation
fleet;
|
· |
Capitalizing
on our favorable capital structure;
and
|
· |
Complementing
our existing businesses through our Internet
solutions.
|
· |
increased
our operating profit margin from 3.78% in 2003 to 3.88%;
|
· |
canceled,
created and reduced some of the distribution routes to increase
their
profitability;
|
· |
reviewed,
and in some cases changed, the commercial terms of several of our
clients
and supplier. In certain instances, we stopped distributing product
lines
for some suppliers;
|
· |
paid
off in full our cost-bearing liabilities with resources generated
from our
operations. In addition, we ended the year with cash in the amount
of Ps.
481 million;
|
· |
continued
to renew and update our transportation fleet and to enhance a
state-of-the-art distribution network for the warehousing and delivery
of
our various products;
|
· |
maintained
a strong financial position, which allowed us the opportunity to
negotiate
better terms with suppliers; and
|
· |
continued
to develop technologies to improve the efficiency of our operations
and
better serve our clients.
|
|
Year
Ended December 31,(1)
|
|||||||||
2002
|
2003
|
2004
|
||||||||
Sales
in
millions(2)
|
|
U.S.$6,768.3
|
|
U.S.$7,061.7
|
|
U.S.$7,721.3
|
||||
Sales
in millions of units(3)
|
988.0
|
1,005.0
|
972.6
|
|||||||
Average
unit price
|
|
U.S.$6.85
|
|
U.S.$7.03
|
|
U.S.$7.94
|
||||
Growth
in average unit price
|
-1.7
|
%
|
2.6
|
%
|
12.9
|
%
|
(1)
|
Statistics
based on information made publicly available by IMS Health, A.G.
for
private sector data and our estimates.
|
(2)
|
Revenues
based on prices charged by wholesalers to retailers.
|
(3)
|
In
Mexico, pharmaceutical products are distributed in pre-packaged
doses or
units, which may vary in size from year to year.
|
· |
ISSSTE
- The Instituto de Seguridad y Servicios Sociales para los Trabajadores
del Estado, the health and social security institution for Mexican
federal
government employees;
|
· |
PEMEX
-
The hospitals and pharmacies of Petróleos Mexicanos, the Mexican national
oil company. Our sales to PEMEX in 2000 accounted for 4.8% of our
total
net sales and we had 100% of the PEMEX contracts. Due to new conditions
on
our PEMEX contract, sales to PEMEX during 2001 accounted for 3.5%
of our
total net sales and we were awarded with approximately 60% of the
total
PEMEX contracts to serve different hospitals in four specific regions
of
Mexico. During 2002, sales to PEMEX represented approximately 4.0%
of our
total sales, 19.40% higher than in 2001. In 2003, mainly due to
a lower
participation in contracts with PEMEX, sales in our Government
Pharma
Division decreased 29.2% with respect to 2002. Our lower participation
in
PEMEX contracts reflects changes in the terms and conditions of
the
contracts, including changes in the type of products and prices
included
compared to previous years. In 2004, we were able to increase our
participation in various governmental institutions including PEMEX.
As a
result, Government Pharma sales increased 10.1%, and the participation
of
this division to the Group’s total net sales reached 3.0%. We cannot
assume that we will be awarded contracts with PEMEX similar to
those we
have had in previous years; and
|
· |
IMSS-
The hospitals and pharmacies of the Instituto
Mexicano del Seguro Social,
the health and social security institution for Mexican employees
of
private companies.
|
· |
Mexsana
talcum powders from Schering Plough (since
1999);
|
· |
Coppertone
suntan lotions (since 1999);
|
· |
Brunswick
Sea Food products (since 1994);
|
· |
Canderel
and Nutra Sweet products (since 1999);
|
· |
Kraft
Foods (candies division) (since
1999);
|
· |
Veet
Depiladores (since 2002);
|
· |
Cure
Brand (since 2002);
|
· |
The
Sensual Tea (since 2004); and
|
· |
Pringles
(since 2005).
|
· |
Intermex,
a company owned by Televisa, which primarily distributes its own
publications;
|
· |
Codiplyrsa,
which primarily distributes popular magazines nationwide;
and
|
· |
DIMSA,
which distributes primarily English-language publications.
|
Credit
terms
|
Days
|
Pharmacies
|
35
|
Supermarkets
and local wholesalers
|
35
|
Government
|
45
|
Publications
to wholesalers
|
46
|
Publications
to retailers (1)
|
46
|
(1)
|
National
retail chains are centralized.
|
Distribution
Center’s Name
|
Location
(City, State)
|
|
1.
|
Taxqueña
|
Mexico
City, Distrito Federal
|
2.
|
Chihuahua
|
Chihuahua,
Chihuahua
|
3.
|
Coatzacoalcos
|
Coatzacoalcos,
Veracruz
|
4.
|
Culiacán
|
Culiacán,
Sinaloa
|
5.
|
Guadalajara
|
Guadalajara,
Jalisco
|
6.
|
Hermosillo
|
Hermosillo,
Sonora
|
7.
|
Juárez
|
Ciudad
Juárez, Chihuahua
|
8.
|
La
Laguna
|
Gómez
Palacio, Durango
|
9.
|
León
|
León,
Guanajuato
|
10.
|
Centenal
|
Tlalnepantla,
Mexico
|
11.
|
Monterrey
|
Monterrey,
Nuevo León
|
12.
|
Morelia
|
Morelia,
Michoacán
|
13.
|
Peninsular
|
Mérida,
Yucatán
|
14.
|
Citem
|
Tlalnepantla,
Mexico
|
15.
|
Puebla
|
Puebla,
Puebla
|
16.
|
Reynosa
|
Reynosa,
Tamaulipas
|
17.
|
Tampico
|
Tampico,
Tamaulipas
|
18.
|
Tijuana
|
Tijuana,
Baja California
|
19.
|
Tláhuac
|
Mexico
City, Distrito Federal
|
20.
|
Tuxtla
|
Tuxtla
Gutiérrez, Chiapas
|
21.
|
Vallejo
|
Mexico
City, Distrito Federal
|
Distribution
Center’s Name
|
Location
(City, State)
|
|
22.
|
Veracruz
|
Veracruz,
Veracruz
|
|
Year
Ended December 31,
|
|||||||||
2002
|
2003
|
2004
|
||||||||
Total
Private Pharmaceuticals
Market:
|
||||||||||
Real
Unit Price Increases
|
7.2
|
%
|
7.6
|
%
|
6.6
|
%
|
||||
Growth
in Units
|
2.3
|
%
|
1.7
|
%
|
-3.2
|
%
|
||||
Grupo
Casa Saba Private
Pharmaceutical
Products:
|
||||||||||
Real
Unit Price Increases
|
5.5
|
%
|
4.2
|
%
|
7.2
|
%
|
||||
Growth
in Units
|
1.3
|
%
|
1.5
|
%
|
-6.8
|
%
|
||||
Market
Share of Grupo Casa Saba(1):
|
28.0
|
%
|
27.9
|
%
|
26.0
|
%
|
||||
Inflation(2)
|
5.7
|
%
|
4.0
|
%
|
5.2
|
%
|
(1)
|
Based
on information from IMS Health, A.G. and Grupo Casa Saba estimates.
This
market share does not include purchases made by government institutions
and sales in the private pharmaceutical market from similares,
generics
and impulso.
|
(2)
|
Based
on the changes in the NCPI
|
Year
Ended December 31,
|
||||||||||
2002
|
2003
|
2004
|
||||||||
(Millions
of constant Pesos as of December 31, 2004)
|
||||||||||
Pharmaceuticals:
|
||||||||||
Private
sector
|
Ps.16,220.3
|
Ps.17,160.8
|
Ps.17,185.6
|
|||||||
%
Growth
|
6.9
|
%
|
5.8
|
%
|
0.1
|
%
|
||||
Government
|
791.1
|
560.7
|
617.5
|
|||||||
%
Growth
|
19.4
|
%
|
-29.2
|
%
|
10.1
|
%
|
||||
Health,
Beauty, Consumer Goods, General Merchandise and Other
Products
|
2,132.5
|
2,152.4
|
2,054.3
|
|||||||
%
Growth
|
1.8
|
%
|
0.9
|
%
|
-4.6
|
%
|
||||
Publications
|
770.2
|
671.2
|
712.6
|
|||||||
%
Growth
|
(8.5
|
)%
|
(12.9
|
)%
|
6.2
|
%
|
||||
Total
|
Ps.19,914.1
|
Ps.20,545.1
|
Ps.20,570.0
|
|||||||
Total
% Growth
|
6.1
|
%
|
3.2
|
%
|
0.1
|
%
|
Year
Ended December 31,
|
||||||||||
2002
|
2003
|
2004
|
||||||||
Pharmaceuticals:
|
||||||||||
Private
|
81.4
|
%
|
83.5
|
%
|
83.6
|
%
|
||||
Government
|
4.0
|
%
|
2.7
|
%
|
3.0
|
%
|
||||
Health,
Beauty, Consumer Goods, General Merchandise and Other
Products
|
10.7
|
%
|
10.5
|
%
|
9.9
|
%
|
||||
Publications
|
3.9
|
%
|
3.3
|
%
|
3.5
|
%
|
||||
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
|||||
Cost
of Sales
|
89.5
|
%
|
90.1
|
%
|
89.7
|
%
|
||||
Gross
Profit
|
10.5
|
%
|
9.9
|
%
|
10.3
|
%
|
||||
Operating
expenses:
|
||||||||||
Selling
expenses
|
2.9
|
%
|
2.5
|
%
|
2.7
|
%
|
||||
Administrative
expenses
|
3.8
|
%
|
3.7
|
%
|
3.7
|
%
|
||||
6.7
|
%
|
6.2
|
%
|
6.4
|
%
|
|||||
Operating
income
|
3.9
|
%
|
3.8
|
%
|
3.9
|
%
|
||||
Comprehensive
cost of financing, net
|
0.1
|
%
|
0.2
|
%
|
0.0
|
%
|
||||
Other
income
|
0.0
|
%
|
(0.2
|
)%
|
(0.2
|
)%
|
||||
Income
tax and employee profit sharing
|
0.8
|
%
|
0.8
|
%
|
0.9
|
%
|
||||
Net
income
|
3.0
|
%
|
2.9
|
%
|
3.2
|
%
|
||||
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
Contractual
Obligations
|
Payments
due by period
|
||||
Total
|
Less
than 1 year
|
1-3
years
|
3-5
years
|
More
than 5 years
|
Long
Term Debt (1)
|
-
|
-
|
-
|
-
|
-
|
Capital
Lease Obligations (2)
|
17,073
|
17,073
|
-
|
-
|
-
|
Operating
Leases (3)
|
-
|
-
|
-
|
-
|
-
|
Purchase
Obligations (4)
|
-
|
-
|
-
|
-
|
-
|
Other
Long Term Liabilities reflected on our Balance Sheet Under Mexican
GAAP
(5)
|
53,821
|
-
|
-
|
-
|
53,821
|
Total
|
70,894
|
17,073
|
-
|
-
|
53,821
|
(i) |
The
statutory income tax rate will be 30% for 2005 and will be reduced
by one
percentage point per year through 2007, when the rate will be
28%.
|
(ii) |
The
tax deduction for inventories will be made through cost of sales,
and the
inventory balance as of December 31, 2004, will be taxable during
the next
four to twelve years, based on specific criteria provided for
in the
Income Tax Law.
|
(iii) |
Paid
employee profit sharing will be deductible from income tax,
and
|
(iv) |
The
limit on stockholders’ participation in taxable income or loss from
Mexican subsidiaries will be eliminated for tax consolidation
purposes.
|
Directors
Name
and Date of Birth
|
Principal
Occupation
|
Business
Experience
|
First
Elected
|
Isaac
Saba Raffoul
(10/17/23)
|
Chairman
of the Board
|
President
and Director -
Xtra
Inmuebles, S.A. de C.V.
|
February
2000
|
Moises
Saba Ades
(07/12/63)
|
Vice
Chairman of the Board
|
Director
- Xtra Inmuebles, S.A. de C.V.
|
February
2000
|
Alberto
Saba Ades
(07/09/65)
|
Vice
Chairman of the Board
|
Director
- Xtra Inmuebles, S.A. de C.V.
|
February
2000
|
Manuel
Saba Ades
(11/03/67)
|
Vice
Chairman of the Board and Chief Executive Officer
|
Director
- Xtra Inmuebles, S.A. de C.V.
|
February
2000
|
Gabriel
Saba D’jamus
(07/27/69)
|
Assistant
Chief Executive Officer
|
Executive
Director - Grupo Comercial Hotelera, S.A. de C.V.
|
February
2000
|
Agustin
Rodriguez Legorreta
(02/11/63)
|
Director
|
Investor
Advisor -Internacional de Capitales, S.A. de C.V.
|
February
2000
|
Raul
Fernandez Diaque
(05/16/63)
|
Director
|
Investor
Advisor -Internacional de Capitales, S.A. de C.V.
|
February
2000
|
Name
and Date of Birth
|
Principal
Occupation
|
Business
Experience
|
First
Elected
|
Ivan
Moguel Kuri
(01/31/63)
|
Tax
Adviser to Grupo Casa Saba, S.A. de C.V.
|
Partner
- Chevez, Ruiz, Zamarripa y Cia, S.C.
|
February
2000
|
Alejandro
Sadurni Gomez
(10/8/59)
|
Chief
Financial Officer
|
Former
Chief Financial Officer of Administration - INMAS, S.A. de
C.V.
|
February
2000
|
· |
one
of our employees or managers;
|
· |
a
controlling shareholder;
|
· |
a
director, executive officer or relative of a controlling shareholder,
or
entities controlled or managed by a controlling shareholder;
or
|
· |
a
significant client, supplier, debtor or creditor, or member of
the board
of directors or executive officer of any of these
entities.
|
· |
prepare
an annual report regarding its activities for submission to the
Board of
Directors and to our shareholders at our annual shareholders’ meeting;
|
· |
prepare
and render statements to the Board of Directors as to the fairness
of
transactions and arrangements with related parties; and
|
· |
retain
independent experts to render fairness opinions in connection with
material transactions and arrangements with related
parties.
|
· |
call
ordinary or extraordinary general
meetings;
|
· |
place
items on the agenda for meetings of shareholders or the Board of
Directors;
|
· |
attend
meetings of shareholders, the Board of Directors, or the Audit
Committee;
and
|
· |
generally
monitor our affairs.
|
Name
and Date of
Birth
|
Current
Position
|
Business
Experience
|
First
Appointed
|
Manuel
Saba Ades
(11/03/67)
|
Chief
Executive Officer and Vice Chairman of the Board
|
President
and Director -Xtra Inmuebles, S.A. de C.V.
|
February
2000
|
Gabriel
Saba D’jamus
(07/27/69)
|
Deputy
Chief Executive Officer
|
Executive
Director - Grupo Comercial Hotelera, S.A. de C.V.
|
February
2000
|
Alejandro
Sadurni Gomez
(10/08/59)
|
Chief
Financial Officer
|
Former
Chief Financial Officer of Administration - INMAS, S.A. de
C.V.
|
February
2000
|
Ricardo
Ríos Cardenas
(01/02/55)
|
North
Region Operations and Sales Director
|
Deputy
Personal Assistant of the President of the United Mexican
States
|
December
2000
|
Oscar
Gutierrez Melgar (17/04/67)
|
South
Region Operations and Sales Director
|
Former
Manager of Drogueros, S.A. de C.V.
|
November
1985
|
Jesus
Guerra de Luna
(05/29/61)
|
General
Counsel
|
Legal
Manager - Grupo Casa Autrey, S.A. de C.V.
|
June
1995
|
Jose
Norberto Mouret
(03/30/52)
|
Human
Resources Director
|
Human
Resources Director - Taesa
|
October
1999
|
Fernando
Torres Suarez
(09/21/64)
|
Purchasing
Director
|
Commercial Director
- Farmacias Benavides
|
April
2001
|
Jorge
Luis Garcia
(09/12/61)
|
Chief
Information Officer
|
Former
Manager - Grupo Casa Autrey, S.A. de C.V.
|
May
1992
|
Name
|
Number
of Ordinary Shares Owned(1)
|
Percentage
Stake
|
Isaac
Saba Raffoul
|
225,606,456
|
85%
|
Directors,
executive officers and key employees(2)
|
225,606,456
|
85%
|
Total
|
225,606,456
|
85%
|
(1)
|
Does
not include Ordinary Shares directly held by funds advised by
Internacional de Capitales, S.A. de C.V., an investment advisory
firm that
renders investment advisory services to funds that invest in securities
of
Latin American and emerging market issuers. Shares held directly
by these
funds as of May 31, 2005 represented less than 3% of our
issued and
outstanding capital stock as of that date. Agustin Rodriguez Legorreta
and
Raul Fernandez Diaque, two members of our Board of Directors, render
investment advisory services to these funds in their capacity as
investment advisors of Internacional de Capitales, S.A. de
C.V.
|
(2)
|
The
only director, executive officer and/or key employee who owns Ordinary
Shares or ADSs is Isaac Saba Raffoul, our controlling shareholder.
The
listed amount is based on information provided by Mr.
Saba.
|
Pesos
per Ordinary Share(1)
|
|||||||
High
|
Low
|
||||||
Year
|
|||||||
2000
|
Ps. |
10.10
|
Ps. |
6.50
|
|||
2001
|
Ps. |
8.99
|
Ps. |
3.69
|
|||
2002
|
Ps. |
12.40
|
Ps. |
6.52
|
|||
2003:
|
Ps. |
13.30
|
Ps. |
10.00
|
|||
First
Quarter
|
12.09
|
10.50
|
|||||
Second
Quarter
|
12.50
|
10.00
|
|||||
Third
Quarter
|
13.30
|
12.30
|
|||||
Fourth
Quarter
|
13.10
|
11.90
|
|||||
2004:
|
Ps. |
16.20
|
Ps. |
12.39
|
|||
First
Quarter
|
14.40
|
12.80
|
|||||
Second
Quarter
|
13.94
|
13.56
|
|||||
Third
Quarter
|
14.15
|
12.39
|
|||||
Fourth
Quarter
|
16.60
|
12.93
|
|||||
2005: | |||||||
First
Quarter
|
Ps. | 20.50 | Ps. | 17.00 | |||
Month
|
|||||||
December
2004
|
Ps. |
16.60
|
Ps. |
15.55
|
|||
January
2005
|
Ps. |
20.50
|
Ps. |
17.00
|
|||
February
2005
|
Ps. |
20.00
|
Ps. |
18.91
|
|||
March
2005
|
Ps. |
18.50
|
Ps. |
18.50
|
|||
April
2005
|
Ps. |
18.50
|
Ps. |
18.50
|
|||
May
2005
|
18.50
|
18.50
|
|||||
June
(through June 15, 2005)
|
17.90
|
16.70
|
(1)
|
Source:
Infosel and Economática
|
U.S.
Dollars per ADS(1)
|
|||||||
High
|
Low
|
||||||
Year
|
|||||||
2000
|
U.S.$ |
$11.00
|
U.S.$ |
$6.38
|
|||
2001
|
U.S.$ |
8.35
|
U.S.$ |
5.05
|
|||
2002
|
U.S.$ |
12.51
|
U.S.$ |
6.60
|
|||
2003:
|
U.S.$ |
12.50
|
U.S.$ |
9.40
|
|||
First
Quarter
|
11.65
|
9.70
|
|||||
Second
Quarter
|
11.90
|
9.40
|
|||||
Third
Quarter
|
12.50
|
11.50
|
|||||
Fourth
Quarter
|
11.60
|
10.45
|
|||||
2004:
|
U.S.$ |
14.99
|
U.S.$ |
10.70
|
|||
First
Quarter
|
13.01
|
11.40
|
|||||
Second
Quarter
|
13.00
|
12.11
|
|||||
Third
Quarter
|
11.83
|
10.70
|
|||||
Fourth
Quarter
|
14.99
|
11.25
|
|||||
2005:
|
|||||||
First
Quarter
|
U.S.$ | 18.50 | U.S.$ | 14.75 | |||
Month
|
|||||||
December
2004
|
U.S.$ |
14.99
|
U.S.$ |
13.45
|
|||
January
2005
|
U.S.$ |
18.50
|
U.S.$ |
14.75
|
|||
February
2005
|
U.S.$ |
18.10
|
U.S.$ |
16.85
|
|||
March
2005
|
U.S.$ |
17.20
|
U.S.$ |
16.12
|
|||
April
2005
|
U.S.$ |
16.77
|
U.S.$ |
16.25
|
|||
May
2005
|
U.S.$ |
16.65
|
U.S.$ |
14.80
|
|||
June
(through June 15, 2005)
|
U.S.$ |
15.69
|
U.S.$ |
14.95
|
· |
establish
a Board of Directors with at least five and not more than twenty
members
and alternate members, of which 25% must qualify as “independent
directors” as defined under Mexican law;
|
· |
adopt
specified corporate governance measures, which require us to establish,
among other things, an audit committee, as well as more stringent
procedures for the approval of transactions and arrangements with
related
parties and corporate transactions out of the ordinary course of
business;
and
|
· |
provide
additional protections for minority
shareholders.
|
· |
to
be considered as Mexicans with respect to Ordinary Shares that
they
acquire or hold as well as to the property, rights, concessions,
participations or interests owned by us or to the rights and obligations
derived from any agreements we have with the Mexican government;
and
|
· |
not
to invoke the protection of their own governments. Failure to comply
is
subject to a penalty of forfeiture of such a shareholder’s capital
interests in favor of Mexico.
|
· |
any
redemption shall be made on a pro-rata basis among all of our
shareholders;
|
· |
to
the extent that a redemption is effected through a public tender
offer on
the Mexican Stock Exchange, the shareholders’ resolution approving the
redemption may empower the Board of Directors to specify the number
of
shares to be redeemed and appoint the related intermediary or purchase
agent; and
|
· |
any
redeemed shares must be cancelled.
|
·
|
holders
of at least 10% of our outstanding capital stock to call a shareholders’
meeting;
|
· |
holders
of at least 15% of our outstanding capital stock to bring a derivative
suit against any member of our Board of Directors for breach of
fiduciary
duties;
|
· |
holders
of at least 10% of our shares represented at a shareholders’ meeting to
request that resolutions with respect to any matter on which they
were not
sufficiently informed to be postponed; and
|
· |
subject
to the satisfaction of certain requirements under Mexican law,
holders of
at least 20% of our outstanding capital stock to contest any shareholder
resolution.
|
· |
to
be considered as Mexicans with respect to the Ordinary Shares that
they
acquire or hold, as well as to the property, rights, concessions,
participation or interests owned by us or to the rights and obligations
derived from any agreements we have with the Mexican government;
and
|
· |
not
to invoke the protection of their own governments. If a holder
of our
Ordinary Shares invokes the protection of its own government, the
holder’s
Ordinary Shares will be forfeited to the Mexican
government.
|
· |
The
Income Tax Law
|
· |
The
Federal Tax Code, and
|
· |
The
Tax Treaty between Mexico and the U.S., which we refer to as the
Tax
Treaty.
|
· |
a
natural person may be treated as a resident of Mexico if he or
she has
established his or her home in Mexico, unless he or she resided
in another
country for more than 183 calendar days during a year and can demonstrate
that he or she had become a resident of that country for tax
purposes;
|
· |
a
legal entity is a resident of Mexico if it is established under
Mexican
law, or it has established in Mexico its main place of
management;
|
· |
a
Mexican citizen is presumed to be a resident of Mexico unless he
or she
can demonstrate otherwise; and
|
· |
a
legal entity that has a permanent establishment or fixed base in
Mexico
shall be required to pay taxes in accordance with relevant tax
provisions.
|
· |
the
sale is carried out through the Mexican Stock Exchange, or other
recognized securities market approved by the Mexican tax authorities
through general rules; and
|
· |
the
Ministry of Finance and Public Credit considers such Ordinary Shares
to be
publicly held.
|
· |
a
citizen or resident of the United
States;
|
· |
a
corporation or other entity taxable as a corporation organized
or created
in the United States or any political subdivision thereof; as the
case may
be;
|
· |
an
estate, the income of which is subject to U.S. federal income tax,
regardless of its source or
|
· |
a
trust, if a court within the United States is able to exercise
primary
supervision over its administration and one or more United States
persons
have the authority to control all substantial decisions of such
trust
|
NYSE
Standards
|
Our
Corporate Governance Practice
|
|
Majority
of board of directors must be independent. Exception for
“controlled
companies,” which would include our company if we were a U.S.
issuer.
|
We
are required to have a board of directors of between 5 and
20 members, 25%
of whom must be independent under the Mexican Stock Exchange
Law. Our
board of directors is not required to make a determination
as to the
independence of our directors. The applicable definition
of independence,
which differs in certain respects from the definition applicable
to U.S.
issuers under the NYSE standard, prohibits, among other relationships,
an
independent director from being an employee or officer of
the company or
an independent director from being a shareholder that may
have influence
over the company. It also prohibits certain relationships
between the
company and the independent director, entities with which
the independent
director is associated and family members of the independent
director.
|
Non-management
directors must meet at executive sessions without
management.
|
Our
non-management directors are not required to meet in executive
sessions.
Executive sessions are not recommended by the Mexican Code
of Enhanced
Corporate Practices. Our Chief Executive Officer is a member
of our board
of directors.
|
|
Nominating/corporate
governance committee of independent directors required.
Exception for
“controlled companies,” which would include our company if we
were a U.S. issuer.
|
We
are not required to have a nominating corporate governance
committee, and
such committee is not recommended by the Mexican Code of
Enhanced
Corporate Practices.
|
|
Compensation
committee of independent directors required. Exception
for “controlled
companies,” which would include our company if we were a U.S.
issuer.
|
We
are not required to have a compensation committee, and
currently we do not
have one.
|
|
Audit
committee satisfying the independence and other requirements
of Rule 10A-3
under the Exchange Act and the NYSE independence
standards.
|
We
have a three member audit committee. Two of these members
are independent
under applicable Mexican standards. We expect to comply
with the independence requirements of Rule 10A-3
prior to July 31,
2005, however, members of our audit committee do not need
to satisfy the
NYSE independence standards that are not required by Rule
10A-3. Our audit
committee does not have a written
charter.
|
Equity
compensation plans require shareholder approval, subject
to limited
exemptions.
|
Shareholder
approval is not required under Mexican law or our
bylaws for the
adoption and amendment of an equity-compensation plan. However,
regulations of the Mexican Banking and Securities Commission
require
shareholder approval under certain circumstances.
|
|
Corporate
governance guidelines and code of conduct and ethics required,
with
disclosure of any waiver for directors or executive officers.
|
The
practices for our board of directors, including committees
and
compensation of directors, are described in this annual
report. We
have adopted a code of ethics applicable to all of our directors
and
executive officers, which is available at http://www.casasaba.com.
|
|
CEO
Certifications must certify to the NYSE each year that the
CEO is not
aware of any violation by the company of the NYSE corporate
governance
listing standards. Additionally CEO’s must notify the NYSE in writing if
any executive officer becomes aware of any material non-compliance
with
the new listing standards.
|
We
are required to disclose each year our degree of compliance
with the Code
of Enhanced Corporate Governance Practices, and the truthfulness
of such
disclosure must be certified by the Chairman of the Board
of Directors,
however there is no such concept as a violation of the Code
of Enhanced
Corporate Governance Practices since compliance with these
is not
mandatory. Furthermore, other than the disclosure provided
by our CEO in
this annual report, the CEO is not required to provide notification
of any
non-compliance of which he may be aware
of.
|
For
the year ended December 31,
|
||||||
2003
|
2004
|
|||||
(Ps.
millions)
|
||||||
Audit
Fees
|
Ps.
|
3.3
|
Ps.
|
5.0
|
||
Audit-Related
Fees
|
.3
|
1.3
|
||||
Tax
Fees
|
2.2
|
3.0
|
||||
Other
Fees
|
0
|
0
|
||||
Total
|
Ps.
|
5.8
|
Ps.
|
9.3
|
Page
|
|
Index
to Consolidated Financial Statements
|
F-1
|
Report
of Independent Registered Public Accounting Firm
|
F-2
|
Consolidated
Balance Sheets as of December 31, 2003 and 2004
|
F-3
|
Consolidated
Statements of Income for each of the years ended
December
31, 2002, 2003 and 2004
|
F-4
|
Consolidated
Statements of Stockholders’ Equity for the years ended
December
31, 2002, 2003 and 2004
|
F-5
|
Consolidated
Statements of Changes in Financial Position for the
years
ended December 31, 2002, 2003 and 2004
|
F-6
|
Notes
to Consolidated Financial Statements
|
F-8
|
Exhibit
Number
|
Description
of Exhibits
|
1.1
|
Amended
and Restated Bylaws (estatutos sociales) of the Registrant (English
Translation) (1).
|
8.1
|
List
of Subsidiaries of the Registrant.
|
12.1
|
Certification
of the Principal Executive Officer of Grupo Casa Saba, S.A. de
C.V.
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
12.2
|
Certification
of the Principal Financial Officer of Grupo Casa Saba, S.A. de
C.V.
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
13.1
|
Certification
of the Principal Executive and Financial Officer of Grupo Casa
Saba, S.A.
de C.V. pursuant to 18 U.S. C. Section 1350, as adopted pursuant
to
Section 906 of the Sarbanes-Oxley Act of
2002.
|
GRUPO
CASA SABA, S.A. DE C.V.,
|
|
by
|
|
/s/
Manuel Saba Ades
|
|
Title:
Chief Executive Officer
|
Page
|
|
Consolidated
Financial Statements of Grupo Casa Saba, S.A. de
C.V.
|
|
Report
of Independent Registered Public Accounting Firm
|
F-2
|
Consolidated
Balance Sheets as of December 31, 2003 and 2004
|
F-3
|
Consolidated
Statement of Income for each of the years ended
December
31, 2002, 2003 and 2004
|
F-4
|
Consolidated
Statements of Stockholders’ Equity for the years ended December 31,
2002,
2003 and 2004
|
F-5
|
Consolidated
Statement of Changes in Financial Position for the years ended
December
31,
2002, 2003 and 2004
|
F-6
|
Notes
to Consolidated Financial Statements
|
F-8
|
Grupo
Casa Saba, S.A. de C.V. and Subsidiaries
|
|||||||||||||||||||||
Consolidated
balance sheets
as
of
december 31, 2003 and 2004
(Amounts
stated in thousands of 2004 year end constant
Mexican pesos
(Ps.) and
thousands of U.S. dollars ($))
|
|||||||||||||||||||||
Convenience
|
Convenience
|
||||||||||||||||||||
2003
|
2004
|
translation
2004
|
2003
|
2004
|
translation
2004
|
||||||||||||||||
CURRENT
ASSETS:
|
CURRENT
LIABILITIES:
|
||||||||||||||||||||
Cash
and cash
equivalents (Note 3.d)
|
Ps. |
179,965
|
Ps. |
481,037
|
$
42,880
|
Bank
loans
(Note 8)
|
Ps. |
410,244
|
Ps. |
—
|
$ —
|
||||||||||
Accounts
receivable, net (Notes 3.f and 4)
|
3,943,433
|
3,580,918
|
319,203
|
Trade
accounts
payable
|
3,757,850
|
4,081,183
|
363,797
|
||||||||||||||
Inventories,
net (Notes 3.c and 5)
|
3,205,754
|
3,694,473
|
329,326
|
Other
payables
and accrued liabilities
|
221,887
|
158,966
|
14,170
|
||||||||||||||
Prepaid
expenses
|
16,552
|
8,604
|
767
|
Employee
profit sharing (Notes 3.l and 12.d)
|
1,508
|
2,764
|
246
|
||||||||||||||
|
|
|
|
||||||||||||||||||
Total
current
assets
|
7,345,704
|
7,765,032
|
692,176
|
Total
current
liabilities
|
4,391,489
|
4,242,913
|
378,213
|
||||||||||||||
RESERVE FOR RETIREMENT PENSIONS AND
|
|||||||||||||||||||||
SENIORITY PREMIUM (Note 3.j)
|
54,347
|
53,821
|
4,798
|
||||||||||||||||||
DEFERRED INCOME TAX (Notes 3.l and 9)
|
739,959
|
789,116
|
70,342
|
||||||||||||||||||
DEFERRED EMPLOYEE PROFIT SHARING
|
—
|
7,917
|
706
|
||||||||||||||||||
PROPERTY
AND
EQUIPMENT, net (Notes 3.c and 6)
|
1,034,959
|
1,069,880
|
95,369
|
Total
liabilities
|
5,185,795
|
5,093,767
|
454,059
|
||||||||||||||
|
|
STOCKHOLDERS'
EQUITY
|
|||||||||||||||||||
Capital
stock
(Note 11)
|
1,007,292
|
1,007,292
|
89,790
|
||||||||||||||||||
Premium
on
stock sold
|
779,720
|
779,720
|
69,504
|
||||||||||||||||||
OTHER
ASSETS,
net
|
87,328
|
83,651
|
7,457
|
Reserve
for
share repurchases (Note 11)
|
952,110
|
952,110
|
84,871
|
||||||||||||||
Retained
earnings
|
2,635,037
|
3,170,087
|
282,582
|
||||||||||||||||||
Deficit
on
restatement (Note 3.c)
|
(1,823,309)
|
(1,839,667)
|
(163,988)
|
||||||||||||||||||
Accrued
deferred income tax effect
|
(36,477)
|
(36,477)
|
(3,251)
|
||||||||||||||||||
GOODWILL,
net
(Note 3.h)
|
232,177
|
208,269
|
18,565
|
Total
stockholders' equity
|
3,514,373
|
4,033,065
|
359,508
|
||||||||||||||
Total
assets
|
Ps. |
8,700,168
|
Ps. |
9,126,832
|
$
813,567
|
Total
liabilities and stockholders' equity
|
Ps. |
8,700,168
|
Ps. |
9,126,832
|
$
813,567
|
||||||||||
2002
|
2003
|
2004
|
Convenience
translation
2004
|
||||||||
Net
sales (Note 3.o)
|
Ps.
|
19,914,146
|
Ps.
|
20,545,077
|
Ps.
|
20,569,977
|
$ 1,833,609
|
||||
Cost
of sales
|
17,813,206
|
18,502,602
|
18,452,387
|
1,644,845
|
|||||||
Gross
profit
|
2,100,940
|
2,042,475
|
2,117,590
|
188,764
|
|||||||
Operating
expenses
|
|||||||||||
Selling
|
586,781
|
511,800
|
564,104
|
50,284
|
|||||||
Administrative
|
746,324
|
754,435
|
755,693
|
67,363
|
|||||||
1,333,105
|
1,266,235
|
1,319,797
|
117,647
|
||||||||
Operating
income
|
767,835
|
776,240
|
797,793
|
71,117
|
|||||||
Comprehensive
cost of financing, net
|
|||||||||||
Interest
income
|
(8,387)
|
(3,191)
|
(6,035)
|
(538)
|
|||||||
Interest
expense
|
78,313
|
66,679
|
29,811
|
2,657
|
|||||||
Exchange
(gain) loss, net (Note 3.m)
|
(2,953)
|
187
|
2
|
-
|
|||||||
Gain
on monetary position (Note 3.c)
|
(49,990)
|
(14,976)
|
(7,984)
|
(712)
|
|||||||
16,983
|
48,699
|
15,794
|
1,407
|
||||||||
Other
income, net
|
(6,483)
|
(36,096)
|
(49,899)
|
(4,448)
|
|||||||
Income
before provisions
|
|||||||||||
757,335
|
763,637
|
831,898
|
74,158
|
||||||||
Provisions
for:
|
|||||||||||
Income
tax (Notes 3.l, 12.a and 12 .e)
|
182,217
|
166,119
|
57,884
|
5,160
|
|||||||
Income
tax offset by prior year tax loss carryforwards
|
(137,439)
|
(135,972)
|
(37,059)
|
(3,303)
|
|||||||
Asset
tax (Note 12.b)
|
9,425
|
—
|
10,342
|
922
|
|||||||
Recovery
of asset tax paid in prior years (Note 12.b)
|
(44,401)
|
—
|
—
|
—
|
|||||||
Deferred
income tax (Notes 3.l and 9)
|
149,149
|
126,138
|
142,418
|
12,695
|
|||||||
158,951
|
156,285
|
173,585
|
15,474
|
||||||||
Employee
profit sharing (Notes 3.j and 12.d)
|
3,468
|
1,508
|
1,592
|
142
|
|||||||
Deferred
employee profit sharing
|
—
|
—
|
7,917
|
706
|
|||||||
162,419
|
157,793
|
183,094
|
16,322
|
||||||||
Net
income
|
Ps.
|
594,916
|
Ps.
|
605,844
|
Ps.
|
648,804
|
$
57,836
|
||||
Net
income per share (Note 3.n)
|
Ps.
|
2.241
|
Ps.
|
2.283
|
Ps.
|
2.444
|
$
0.218
|
||||
Weighted
average shares
|
|||||||||||
outstanding
(in thousands)
|
265,419
|
265,419
|
265,419
|
||||||||
|
|
|||||||||||||||||||||||||
Accrued
|
||||||||||||||||||||||||||
Capital
stock
|
Reserve
for
|
deferred
|
||||||||||||||||||||||||
Premium
on
|
share
|
Retained
|
Deficit
on
|
income
tax
|
||||||||||||||||||||||
Historical
|
Restatement
|
stock
sold
|
repurchases
|
earnings
|
restatement
|
effect
|
Total
|
|||||||||||||||||||
Balances
as of January 1, 2002
|
Ps.
|
167,903
|
Ps.
|
839,389
|
Ps.
|
779,720
|
Ps.
|
952,110
|
Ps.
|
1,541,824
|
Ps.
|
(1,210,994)
|
Ps.
|
(36,477)
|
Ps.
|
3,033,475
|
||||||||||
Comprehensive
income
|
—
|
—
|
—
|
—
|
594,916
|
(367,988)
|
—
|
226,928
|
||||||||||||||||||
Balances
as of December 31, 2002
|
167,903
|
839,389
|
779,720
|
952,110
|
2,136,740
|
(1,578,982)
|
(36,477)
|
3,260,403
|
||||||||||||||||||
Dividends
paid
|
—
|
—
|
—
|
—
|
(107,547)
|
—
|
—
|
(107,547)
|
||||||||||||||||||
Comprehensive
income
|
—
|
—
|
—
|
—
|
605,844
|
(244,327)
|
—
|
361,517
|
||||||||||||||||||
Balances
as of December 31, 2003
|
167,903
|
839,389
|
779,720
|
952,110
|
2,635,037
|
(1,823,309)
|
(36,477)
|
3,514,373
|
||||||||||||||||||
Dividends
paid
|
—
|
—
|
—
|
—
|
(113,754)
|
—
|
—
|
(113,754)
|
||||||||||||||||||
Comprehensive
income
|
—
|
—
|
—
|
—
|
648,804
|
(16,358)
|
—
|
632,446
|
||||||||||||||||||
Balances
as of December 31, 2004
|
Ps.
|
167,903
|
Ps.
|
839,389
|
Ps.
|
779,720
|
Ps.
|
952,110
|
Ps.
|
3,170,087
|
Ps.
|
(1,839,667)
|
Ps.
|
(36,477)
|
Ps.
|
4,033,065
|
Convenience
|
|||||||||||||||||
2002
|
2003
|
2004
|
translation
2004
|
||||||||||||||
Operating
activities:
|
|||||||||||||||||
Net
income
|
Ps.
|
594,916
|
Ps.
|
605,844
|
Ps.
|
648,804
|
$
57,836
|
||||||||||
Add
- Non cash items:
|
|||||||||||||||||
Depreciation
and amortization
|
106,722
|
96,644
|
104,062
|
9,276
|
|||||||||||||
Allowance
for doubtful accounts
|
101,741
|
84,813
|
87,899
|
7,835
|
|||||||||||||
Loss
on sale of property and equipment
|
6,438
|
8,422
|
1,416
|
126
|
|||||||||||||
Provision
for retirement pensions and seniority
premium
|
16,432
|
13,468
|
13,617
|
1,214
|
|||||||||||||
Deferred
income tax
|
149,149
|
126,138
|
142,418
|
12,695
|
|||||||||||||
Deferred
employee profit sharing
|
-
|
-
|
7,917
|
706
|
|||||||||||||
975,398
|
935,329
|
1,006,133
|
89,688
|
||||||||||||||
Changes
in assets and liabilities:
|
|||||||||||||||||
(Increase)
decrease in:
|
|||||||||||||||||
Accounts
receivable
|
(525,874)
|
(489,627)
|
274,616
|
24,479
|
|||||||||||||
Inventories
|
(494,302)
|
(240,787)
|
(505,077)
|
(45,023)
|
|||||||||||||
Prepaid
expenses
|
(3,431)
|
(1,547)
|
7,948
|
708
|
|||||||||||||
Trade
accounts payable
|
284,103
|
(129,970)
|
323,333
|
28,822
|
|||||||||||||
Other
payables and accrued liabilities
|
32,857
|
139,265
|
(62,921)
|
(5,609)
|
|||||||||||||
Employee
profit sharing
|
3,516
|
(2,257)
|
1,256
|
112
|
|||||||||||||
(703,131)
|
(724,923)
|
39,155
|
3,489
|
||||||||||||||
Net
cash provided by operating activities
|
272,267
|
210,406
|
1,045,288
|
93,177
|
|||||||||||||
Investing
activities:
|
|||||||||||||||||
Additions
of property and equipment, net of retirements
|
41,191
|
46,258
|
112,823
|
10,056
|
|||||||||||||
Increase
in other assets
|
3,504
|
2,076
|
2,418
|
216
|
|||||||||||||
Reserve
for retirement pensions and seniority premium
|
(3,846)
|
12,393
|
11,716
|
1,044
|
|||||||||||||
Net
cash used in investing activities
|
40,849
|
60,727
|
126,957
|
11,316
|
|||||||||||||
Financing
activities:
|
|||||||||||||||||
Dividends
paid
|
-
|
(107,547)
|
(113,754)
|
(10,140)
|
|||||||||||||
Bank
loans, net of payments made
|
(311,715)
|
(8,415)
|
(390,000)
|
(34,765)
|
|||||||||||||
Effect
in change of bank loans due to the restatement
|
(42,584)
|
(16,649)
|
(20,244)
|
(1,805)
|
|||||||||||||
Deferred
income tax
|
85,950
|
95,471
|
(93,261)
|
(8,313)
|
|||||||||||||
|
|
|
|
||||||||||||||
Net
cash (used in) financing activities
|
(268,349)
|
(37,140)
|
(617,259)
|
(55,023)
|
|||||||||||||
Convenience
|
|||||||||||||||||
2002
|
2003
|
2004
|
translation
2004
|
||||||||||||||
Net
(decrease) increase in cash and cash
equivalents
|
Ps.
|
(36,931)
|
Ps.
|
112,539
|
Ps.
|
301,072
|
$
26,838
|
||||||||||
Cash
and cash
equivalents at
beginning of year
|
104,354
|
67,426
|
179,965
|
16,042
|
|||||||||||||
|
|||||||||||||||||
Cash
and cash equivalents at
end of year
|
Ps.
|
67,423
|
Ps.
|
179,965
|
Ps.
|
481,037
|
$
42,880
|
||||||||||
Supplementary
information:
|
|||||||||||||||||
Income
tax and asset tax paid
|
Ps.
|
111,022
|
Ps.
|
170,129
|
Ps.
|
96,941
|
$
8,641
|
||||||||||
|
|||||||||||||||||
Employee
profit sharing paid
|
Ps.
|
130
|
Ps.
|
1,371
|
Ps.
|
1,528
|
$
136
|
||||||||||
Interest
paid
|
Ps.
|
66,372
|
Ps.
|
53,583
|
Ps.
|
20,535
|
$ 1,830
|
||||||||||
Economic
Interest
|
||||||
(Direct
or indirect)
|
||||||
2003
|
2004
|
|||||
Casa
Saba, S.A de C.V.
|
(Casa
Saba)
|
99.9%
|
99.9%
|
|||
Drogueros,
S.A. de C.V.
|
(Drogueros)
|
99.9%
|
99.9%
|
|||
Grupo
Mexatar, S.A. de C.V.
|
(Mexatar)
|
99.9%
|
99.9%
|
|||
Centennial,
S.A. de C.V.
|
(Centennial)
|
99.9%
|
99.9%
|
|||
Inmuebles
Visosil, S.A. de C.V.
|
(Visosil)
|
99.9%
|
99.9%
|
|||
Publicaciones
Citem, S.A. de C.V.
|
(Citem)
|
99.9%
|
99.9%
|
|||
Transportes
Marproa, S.A. de C.V.
|
(Marproa)
|
99.9%
|
99.9%
|
|||
Servicios
Corporativos Saba, S.A. de C.V.
|
(Servicios
Corporativos Saba)
|
99.9%
|
99.9%
|
|||
Distribuidora
Casa Saba, S.A. de C.V.
|
(Distribuidora
Saba)
|
99.9%
|
99.9%
|
|||
Other
companies (real estate and service companies)
|
(real
estate and service companies)
|
99.9%
|
99.9%
|
|
December
31,
|
||||||
2003
|
2004
|
||||||
Labor
liability
|
|||||||
Vested
benefit obligation
|
Ps. |
115,178
|
Ps. |
111,207
|
|||
Non-vested
benefit obligation
|
21,437
|
23,491
|
|||||
Accumulated
benefit obligation
|
136,615
|
134,698
|
|||||
Additional
benefit related to future
compensation
increases
|
10,563
|
9,208
|
|||||
Projected
benefit obligation
|
147,178
|
143,906
|
|||||
Fair
value of plan assets
|
50,558
|
57,715
|
|||||
Unfunded
projected benefit obligation
|
96,620
|
86,191
|
|||||
Unrecognized
net transition obligation
|
(44,098
|
)
|
(40,466
|
)
|
|||
Negative
amendments
|
16,927
|
15,921
|
|||||
Unrecognized
net loss
|
(48,094
|
)
|
(38,390
|
)
|
|||
Unfunded
accrued pension cost
and
seniority premium to be recognized
under
U.S. GAAP and Mexican GAAP
|
Ps. |
21,355
|
Ps. |
23,256
|
|||
Additional
Obligation
|
32,992
|
30,565
|
|||||
Net
Actual obligation
|
Ps. |
54,347
|
Ps. |
53,821
|
|||
Components
of the net periodic cost
|
|||||||
Service
cost
|
Ps. |
4,845
|
Ps. |
4,866
|
|||
Interest
on projected benefit obligation
|
8,400
|
7,586
|
|||||
Expected
return on plan assets
|
(4,036
|
)
|
(3,143
|
)
|
|||
Amortization
of net transition obligation
|
3,631
|
3,452
|
|||||
Amortization
of amendments
|
(1,007
|
)
|
(957
|
)
|
|||
Amortization
of losses
|
1,635
|
1,813
|
|||||
Effect
of reduction and/or curtailment on benefit obligation
|
|||||||
|
Ps. |
13,468
|
Ps. |
13,
617
|
|||
Net
periodic cost under U.S. GAAP
and
Mexican GAAP
|
|||||||
December
31
|
|||||||
2003
|
2004
|
||||||
Assumptions
(real rates)
|
|||||||
Discount
rate
|
6
|
%
|
5.5
|
%
|
|||
Salary
increase rate
|
2
|
%
|
1
|
%
|
|||
Return
on plan assets
|
8
|
%
|
7.5
|
%
|
Change
in projected benefit obligation
|
|||||||
Actual
projected benefit obligation at beginning of year
|
Ps.
|
133,262
|
Ps.
|
147,178
|
|||
Service
cost
|
4,606
|
4,866
|
|||||
Interest
cost
|
7,985
|
7,586
|
|||||
Actuarial
loss
|
(15,699
|
)
|
-
|
||||
Benefits
paid
|
9,761
|
(15,724
|
)
|
||||
Inflationary
adjustment
|
7,263
|
-
|
|||||
Projected
benefit obligation at end of year
|
Ps.
|
147,178
|
Ps.
|
143,906
|
|||
Change
in plan assets
|
|||||||
Fair
value of plan assets at beginning of year
|
Ps.
|
42,619
|
Ps.
|
50,558
|
|||
Actual
return on plan assets
|
(14,318
|
)
|
(16,086
|
)
|
|||
Employer
contributions
|
10,000
|
10,372
|
|||||
Benefits
paid
|
9,761
|
12,871
|
|||||
Inflationary
adjustment
|
2,496
|
-
|
|||||
Fair
value of plan assets at end of year
|
Ps.
|
50,558
|
Ps.
|
57,715
|
|||
Funded
status
|
Ps.
|
91,852
|
Ps.
|
86,191
|
|||
Unrecognized
net transition obligation
|
(41,922
|
)
|
(40,466
|
)
|
|||
Negative
amendments
|
16,092
|
15,921
|
|||||
Unrecognized
net loss
|
(45,721
|
)
|
(38,390
|
)
|
|||
Inflationary
adjustment
|
1,054
|
-
|
|||||
Unfunded
accrued pension cost and seniority premium to be recognized
under U.S.
GAAP and Mexican GAAP
|
Ps.
|
21,355
|
Ps.
|
23,256
|
|||
Amounts
recognized in the statement of financial position consist
of:
|
|||||||
Unfunded
accrued pension cost and seniority premium to be
recognized
|
Ps.
|
20,301
|
Ps.
|
23,256
|
|||
Accrued
benefit liability
|
(65,713
|
)
|
(60,981
|
)
|
|||
Intangible
asset
|
31,364
|
30,565
|
|||||
Accumulated
other comprehensive income
|
34,349
|
30,416
|
|||||
Inflationary
adjustment
|
1,054
|
-
|
|||||
1,054
|
-
|
||||||
Net
amount recognized
|
Ps.
|
21,355
|
Ps.
|
23,256
|
i)
|
The
Group records the provision for both income tax and employee
profit
sharing based on the amount payable which is determined
based on taxable
income.
|
ii)
|
The
deferred income tax effect and deferred employee profit
sharing are
determined by applying the “comprehensive asset and liability method” in
accordance with Mexican GAAP. Pursuant to this method,
the deferred income
tax liability is recorded for all temporary differences.
On the other
hand, the deferred income tax asset is only recorded under
certain
circumstances. The deferred income tax liability and/or
asset are
classified as a noncurrent item. The deferred income tax
liability and/or
asset are determined by applying the income tax rate to
the temporary
differences between the accounting and tax values of assets
and
liabilities as of the date of the relevant financial statements,
as well
as the amount of the tax loss carryforwards. In the event
of any change in
the income tax rate effective subsequent to the fiscal
year end, the
income tax rate that will be affected at the time it is
estimated that the
temporary differences are realized will be applied. Asset
tax paid in the
current year and in prior years that are recoverable may
be recognized as
a deferred income tax asset under certain
circumstances.
|
iii)
|
The
Group prepares its income tax return and asset tax return
on a
consolidated basis. The Group’s consolidated subsidiaries meet the
characteristics set forth in the Income Tax Law for "controlled
companies". The Group recognizes the impact of the eliminations
that
should be recorded for book and tax consolidation purposes.
Consequently,
the Group’s consolidated financial statements reflect the amount
of the
provision for income tax of the Company and that of its
consolidated
subsidiaries, adjusted for the impact of
consolidation.
|
2003
|
2004
|
||||||
Trade
receivables
|
Ps. |
3,898,714
|
Ps. |
3,607,961
|
|||
Allowance
for doubtful accounts
|
(270,478
|
)
|
(315,311
|
)
|
|||
3,628,236
|
3,292,650
|
||||||
Other
receivables
|
57,192
|
68,687
|
|||||
Related
parties
|
3,696
|
3,664
|
|||||
Value
added tax recoverable
|
33,746
|
57,120
|
|||||
Income
tax recoverable
|
208,967
|
145,822
|
|||||
Asset
tax recoverable
|
11,596
|
12,975
|
|||||
|
Ps. | 3,943,433 | Ps. |
3,580,918
|
|||
2003
|
2004
|
||||||
Pharmaceutical
products
|
Ps. |
2,263,298
|
Ps. |
Ps.2,442,179
|
|||
Beauty
care products
|
298,964
|
308,692
|
|||||
Books
and magazines
|
309,292
|
275,438
|
|||||
Electric
appliances
|
3,905
|
3,464
|
|||||
Groceries
|
62,203
|
87,829
|
|||||
Other
|
12,498
|
11,882
|
|||||
2,950,160
|
3,129,484
|
||||||
Estimate
for low-moving inventory
|
(7,382
|
) |
(7,017
|
)
|
|||
2,942,778
|
3,122,467
|
||||||
Merchandise-in-transit
|
262,976
|
572,006
|
|||||
|
Ps. |
3,205,754
|
Ps. |
3,694,473
|
|||
2003
|
2004
|
||||||||||||
|
|
|
Total
|
Original
cost |
Restatement
|
Total
|
|||||||
Buildings
|
Ps. |
810,669
|
Ps. |
242,722
|
Ps. |
568,361
|
Ps. |
811,083
|
|||||
Machinery
and equipment
|
90,102
|
38,858
|
52,084
|
90,942
|
|||||||||
Transportation
equipment
|
242,470
|
154,361
|
76,525
|
230,886
|
|||||||||
Office
equipment
|
138,679
|
43,662
|
95,481
|
139,143
|
|||||||||
Computer
equipment
|
284,395
|
148,234
|
145,839
|
294,073
|
|||||||||
1,566,315
|
627,837
|
938,290
|
1,566,127
|
||||||||||
Less-accumulated
depreciation
|
(815,242
|
)
|
(291,297
|
)
|
(514,846
|
)
|
(806,143
|
)
|
|||||
751,073
|
336,540
|
423,444
|
759,984
|
||||||||||
Land
|
283,886
|
55,151
|
254,745
|
309,896
|
|||||||||
|
Ps. | 1,034,959 | Ps. |
391,691
|
Ps. |
678,189
|
Ps. |
1,069,880
|
Buildings
and improvements
|
2.10%
|
Machinery
and equipment
|
6.09%
|
Transportation
equipment
|
10.15%
|
Furniture
and fixtures
|
6.50%
|
Computer
equipment
|
11.15%
|
2003
|
2004
|
||
Aeroxtra,
S.A. de C.V.
|
Ps.
3,696
|
Ps.
2,000
|
|
Xtra
Inmuebles, S.A. de C.V.
|
-
|
1,664
|
|
|
Ps.
3,696
|
Ps.
3,664
|
a)
|
On
December 31, 2003, Casa Saba obtained an unsecured loan
from Scotiabank
Inverlat, S.A. (Scotiabank) in the amount of Ps. 390,000
(Ps. 410,244 at
fiscal year end constant Mexican pesos), which bore interest
at a 7.29%
annual market rate. The proceeds from this loan were
used for the working
capital. The loan was paid in full on its due date, January
7,
2004.
|
b)
|
Through
a "mortgage backed clean credit opening contract" with
Scotiabank dated
June 29, 2001, Casa Saba obtained a loan in the amount
of Ps. 645,000 (Ps.
762,435 at fiscal year end constant Mexican pesos). The
proceeds from this
loan were used to prepay the aggregate amount of the
outstanding
restructured indebtedness previously acquired with Banco
Nacional de
Mexico dated December 5,
2000.
|
c)
|
On
December 16, 2002, Casa Saba obtained an unsecured loan
from Scotiabank in
the amount of Ps. 200,000 (Ps. 218,748 at fiscal year
end constant Mexican
pesos). This loan bore interest at a 9.3% annual market
rate. The proceeds
from this loan were used for the working capital. This
loan was paid in
full on its due date, February 14,
2003.
|
d)
|
Applicable
interest rates are adjusted monthly, in accordance with
market rates
hence, as of December 31, 2003 the carrying value of
the bankig debt
approximates its market
value.
|
2003
|
2004
|
||||||
Excess
of book over
|
|||||||
tax
value of assets and liabilities, net
|
Ps. |
2,945,877
|
Ps. |
3,827,886
|
|||
Tax
loss carryforwards
|
(504,350
|
)
|
(732,945
|
)
|
|||
2,441,527
|
3,094,941
|
||||||
Income
tax rate
|
33
|
%
|
28
|
%
|
|||
Deferred
income tax
|
805,704
|
866,583
|
|||||
Less-
|
|||||||
Asset
tax recoverable
|
(65,745
|
)
|
(77,467
|
)
|
|||
Deferred
income tax liability effect
|
Ps. |
739,959
|
Ps. |
789,116
|
2003
|
2004
|
||||||
Current
assets
|
$
|
3,972
|
$
|
5,375
|
|||
Current
liabilities
|
1,453
|
1,014
|
|||||
Net
position in U.S. dollars
|
$
|
2,519
|
$
|
4,361
|
|||
Net
position (at fiscal year end constant Mexican pesos)
|
Ps. |
28,220
|
Ps. |
48,925
|
|
Par
value
|
|||||||||
Number
|
2003
|
2004
|
||||||||
Fixed
capital shares without retirement rights
|
265,149,080
|
Ps.
|
167,730
|
Ps.
|
167,730
|
|||||
Variable
capital shares
|
270,280
|
173
|
173
|
|||||||
265,419,360
|
Ps.
|
167,903
|
Ps.
|
167,903
|
||||||
At
fiscal year end constant Mexican pesos
|
Ps.
|
1,007,292
|
Ps.
|
1,007,292
|
2002
|
2003
|
2004
|
|||||||||
Income
tax due
|
Ps. |
182,217
|
Ps. |
166,119
|
Ps. |
57,884
|
|||||
Income
tax offset by prior year tax loss carryforwards
|
(137,439
|
)
|
(
135,972
|
)
|
(37,059
|
)
|
|||||
Deffered
income tax
|
149,149
|
126,138
|
142,418
|
||||||||
193,927
|
156,285
|
163,243
|
|||||||||
Asset
tax, net of recovery
|
(34,976
|
)
|
-
|
10,342
|
|||||||
|
Ps. |
158,951
|
Ps. |
156,285
|
Ps. |
173,585
|
|
Year
|
Tax
loss
|
Asset
tax
|
Year
of
|
|||||||
incurred
|
Carryforward
|
recoverable
|
Expiration
|
|||||||
1995
|
Ps. |
-
|
Ps. |
4,043
|
2005
|
|||||
1996
|
-
|
15,152
|
2006
|
|||||||
1998
|
240,979
|
-
|
2008
|
|||||||
2000
|
190,485
|
-
|
2010
|
|||||||
2001
|
194,553
|
2,376
|
2011
|
|||||||
2002
|
-
|
8,746
|
2012
|
|||||||
2003
|
-
|
31,005
|
2013
|
|||||||
2004
|
-
|
10,623
|
2014
|
|||||||
|
Ps. | 626,017 | Ps. |
71,945
|
|
Year
ended December, 31
|
|||||||||||||||||
2002
|
2003
|
2004
|
||||||||||||||||
Statutory
income tax rate
|
35
|
%
|
34
|
%
|
33
|
%
|
||||||||||||
Permanent
differences:
|
||||||||||||||||||
Comprehensive
cost of financing vs. annual inflationary adjustment
|
-
|
3
|
15
|
|||||||||||||||
Non-deductible
items
|
(12
|
)
|
(10
|
)
|
(35
|
)
|
||||||||||||
Other
(including inflation effects)
|
74
|
-
|
-
|
|||||||||||||||
Temporary
differences:
|
||||||||||||||||||
Depreciation
|
13
|
4
|
9
|
|||||||||||||||
Book
cost of sales vs. purchases, labor and overhead
|
39
|
16
|
225
|
|||||||||||||||
Application
of prior year tax loss carryforwards
|
(149
|
) |
(26.5
|
) |
(226.1
|
) | ||||||||||||
0
|
%
|
20.5
|
%
|
20.9
|
%
|
|
Millions
of Mexican pesos
|
|||||||||
2002
|
2003
|
2004
|
||||||||
Pharmaceutical
products
|
Ps. |
17,013
|
Ps. |
17,722
|
Ps. |
17,803
|
||||
Health
and beauty aids/other products
|
1,925
|
1,975
|
1,882
|
|||||||
Entertainment
products
|
770
|
671
|
713
|
|||||||
Food/non-perishable
products
|
168
|
156
|
170
|
|||||||
Office/electronic
products
|
38
|
21
|
2
|
|||||||
Total
|
Ps. |
19,914
|
Ps. |
20,545
|
Ps. |
20,570
|
|
|
CONSTANT
MEXICAN PESOS
|
|||||||||||
|
MEXICAN
GAAP
|
U.S.
GAAP
|
|||||||||||
2003
|
2004
|
2003
|
2004
|
||||||||||
Current
|
Ps. |
-
|
Ps. |
-
|
Ps. |
900,170
|
Ps. |
967,275
|
|||||
Noncurrent
|
739,959
|
789,116
|
(160,211
|
)
|
(178,159
|
)
|
|||||||
|
Ps. |
739,959
|
Ps. |
789,116
|
Ps. |
739,959
|
Ps. |
789,116
|
|||||
DEFERRED
EMPLOYEE PROFIT SHARING
|
||||||||||
|
|
CONSTANT
MEXICAN PESOS
|
||||||||
2002
|
|
|
2003
|
|
|
2004
|
||||
Current
|
|
|||||||||
Inventories
|
Ps. |
62,605
|
Ps. |
Ps.
298,000
|
Ps. |
27,535
|
||||
Non-deductible
reserves
|
(5,590
|
)
|
(100,768
|
)
|
-
|
|||||
57,015
|
197,232
|
27,535
|
||||||||
|
|
|||||||||
Non-current
|
|
|
||||||||
Property
and equipment
|
2,998
|
392
|
||||||||
Prepaid
expenses and prepaid pension cost
|
1,646
|
(46
|
)
|
|||||||
Other
|
-
|
(197,578
|
)
|
(19,618
|
)
|
|||||
4,644
|
(197,232
|
)
|
(19,618
|
)
|
||||||
|
Ps. | 61,659 | Ps. |
-
|
Ps. |
7,917
|
|
Thousands
of Mexicsn pesos (Ps.) and thousands of U.S. dollars
($), except per
share
|
||||||||||||
NET
INCOME
|
Year
|
Convenience
translation
|
|||||||||||
2002
|
2003
|
2004
|
2004
|
||||||||||
Net
income under Mexican
GAAP
|
Ps.
|
594,916
|
Ps.
|
605,844
|
Ps.
|
648,804
|
$
|
57,836
|
|||||
U.S.
GAAP adjustments-
|
|||||||||||||
Deferred
employee profit sharing
|
(53,421
|
)
|
59,301
|
-
|
-
|
||||||||
Amortization
of goodwill
|
24,137
|
-
|
-
|
-
|
|||||||||
Impact
of inflation accounting
on U.S. GAAP ad
justments
|
472
|
2,358
|
-
|
-
|
|||||||||
(28,812
|
)
|
61,659
|
-
|
||||||||||
Net
income under U.S. GAAP
|
Ps.
|
566,104
|
Ps.
|
667,503
|
Ps.
|
648,804
|
$
|
57,836
|
|||||
Weighted
average common
shares
outstanding (thousands)
|
265,419
|
265,419
|
265,419
|
||||||||||
Basic
and diluted earnings per share under U.S. GAAP
|
Ps.
|
2.13
|
Ps.
|
2.51
|
Ps.
|
2.44
|
STOCKHOLDERS’
EQUITY
|
Convenience
translation
|
||||||||||||
2002
|
2003
|
2004
|
2004
|
||||||||||
Stockholders’
equity under Mexican
GAAP
|
|
3,260,403
|
$
|
3,514,373
|
$
|
4,033,065
|
$
|
359,508
|
|||||
|
|||||||||||||
U.S.
GAAP adjustments-
|
|||||||||||||
Deferred
employee profit
Sharing
|
(61,659
|
)
|
-
|
-
|
-
|
||||||||
Amortization
of goodwill
|
24,137
|
24,137
|
24,137
|
2,151
|
|||||||||
(37,522
|
)
|
24,137
|
24,137
|
2,151
|
|||||||||
Stockholders’
equity under
U.S.
GAAP
|
$
|
3,222,881
|
$
|
3,538,510
|
$
|
4,057,202
|
$
|
361,659
|
|||||
Convenience
|
|||||||||||||
translation
|
|||||||||||||
2002
|
2003
|
2004
|
2004
|
||||||||||
Stockholders’
equity under
|
|||||||||||||
U.S.
GAAP as of beginning of the year
|
Ps.
|
3,061,242
|
Ps.
|
3,222,881
|
Ps.
|
3,538,510
|
$
|
315,421
|
|||||
Comprehensive
income under U.S. GAAP
|
198,116
|
423,176
|
632,446
|
56,378
|
|||||||||
Reversal
of deferred income tax
|
(36,477
|
)
|
-
|
-
|
-
|
||||||||
Dividends
paid
|
-
|
(107,547
|
)
|
(113,754
|
)
|
(10,140
|
)
|
||||||
Stockholders’
equity under U.S. GAAP at year end
|
Ps.
|
3,222,881
|
Ps.
|
3,538,510
|
Ps.
|
4,057,202
|
$
|
361,659
|
|
|
|
|
|
|
|
|
|
|
|
|
Convenience
|
|
translation
|
|||||||||||||
2002
|
2003
|
2004
|
2004
|
||||||||||
Net
income under U.S. GAAP
|
Ps.
|
566,104
|
Ps.
|
667,503
|
Ps.
|
648,804
|
$
|
57,836
|
|||||
Deficit
on holding nonmonetary assets
|
(367,988
|
)
|
(244,327
|
)
|
(16,358
|
)
|
(1,458
|
)
|
|||||
Comprehensive
income under U.S. GAAP
|
Ps.
|
198,116
|
Ps.
|
423,176
|
Ps.
|
632,446
|
$
|
56,378
|
|||||
Exhibit
Number
|
Description
of Exhibits
|
1.1
|
Amended
and Restated Bylaws (estatutos sociales) of the Registrant
(English
Translation) (1).
|
8.1
|
List
of Subsidiaries of the Registrant.
|
12.1
|
Certification
of the Principal Executive Officer of Grupo Casa Saba,
S.A. de C.V.
pursuant to Section 302 of the Sarbanes-Oxley Act of
2002.
|
12.2
|
Certification
of the Principal Financial Officer of Grupo Casa Saba,
S.A. de C.V.
pursuant to Section 302 of the Sarbanes-Oxley Act of
2002.
|
13.1
|
Certification
of the Principal Executive and Financial Officer of Grupo
Casa Saba, S.A.
de C.V. pursuant to 18 U.S. C. Section 1350, as adopted
pursuant to
Section 906 of the Sarbanes-Oxley Act of
2002.
|